COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 2574: Articles 25731-25740  | Next

ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets
Blair, R. V., Vaccari, M., Doyle-Meyers, L. A., Roy, C. J., Russell-Lodrigue, K., Fahlberg, M., Monjure, C. J., Beddingfield, B., Plante, K. S., Plante, J. A., Weaver, S. C., Qin, X., Midkiff, C. C., Lehmicke, G., Golden, N., Threeton, B., Penney, T., Allers, C., Barnes, M. B., Pattison, M., Datta, P. K., Maness, N. J., Birnbaum, A., Bohm, R. P., Rappaport, J.
10.1101/2020.06.18.157933 — Posted: 2020-06-19
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
Dittmar, M., Lee, J. S., Whig, K., Segrist, E., Li, M., Jurado, K., Samby, K., Ramage, H., Schultz, D., Cherry, S.
10.1101/2020.06.19.161042 — Posted: 2020-06-19 Discussion: Onsite | Offsite
A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge
Yahalom-Ronen, Y., Tamir, H., Melamed, S., Politi, B., Shifman, O., Achdout, H., B. Vitner, E., Israeli, O., Milrot, E., Stein, D., Cohen-Gihon, I., Lazar, S., Gutman, H., Glinert, I., Cherry, L., Vagima, Y., Lazar, S., Weiss, S., Ben-Shmuel, A., Avraham, R., Puni, R., Lupu, E., Bar David, E., Sittner, A., Erez, N., Zichel, R., Mamroud, E., Mazor, O., Levy, H., Laskar, O., Yitzhaki, S., C. Shapira, S., Zvi, A., Beth-Din, A., Paran, N., Israely, T.
10.1101/2020.06.18.160655 — Posted: 2020-06-19 Discussion: Onsite
Identification of a critical horseshoe-shaped region in the nsp5 (Mpro, 3CLpro) protease interdomain loop (IDL) of coronavirus mouse hepatitis virus (MHV)
Nick, B. C., Pandya, M. C., Lu, X., Franke, M. E., Callahan, S. M., Hasik, E. F., Berthrong, S. T., Denison, M. R., Stobart, C. C.
10.1101/2020.06.18.160671 — Posted: 2020-06-19
Mechanism and inhibition of SARS-CoV-2 PLpro
Klemm, T., Ebert, G., Calleja, D. J., Allison, C. C., Richardson, L. W., Bernardini, J. P., Lu, B. G. C., Kuchel, N. W., Grohmann, C., Shibata, Y., Gan, Z. Y., Cooney, J. P., Doerflinger, M., Au, A. E., Blackmore, T. R., Geurink, P. P., Ovaa, H., Newman, J., Riboldi-Tunnicliffe, A., Czabotar, P. E., Mitchell, J. P., Feltham, R., Lechtenberg, B. C., Lowes, K. N., Dewson, G., Pellegrini, M., Lessene, G., Komander, D.
10.1101/2020.06.18.160614 — Posted: 2020-06-19 Discussion: Onsite
Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19
Vogelzang, E. H., Loeff, F. C., Derksen, N. I., Kruithof, S., Ooijevaar-de Heer, P., van Mierlo, G., Linty, F., Mok, J. Y., van Esch, W., de Bruin, S., Vlaar, A. P., Seppen, B., Leeuw, M., van Oudheusden, A. J., Buiting, A. G., Jim, K. K., Vrielink, H., Swaneveld, F., Vidarsson, G., van der Schoot, C. E., Wever, P., Li, W., van Kuppeveld, F. J., Murk, J.-L., Bosch, B. J., Wolbink, G. J., Rispens, T.
10.1101/2020.06.17.20133793 — Posted: 2020-06-19
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis of confounder-adjusted 20212 hospitalized patients
Kim, M. S., An, M. H., Kim, W. J., Hwang, T.-H.
10.1101/2020.06.15.20132407 — Posted: 2020-06-19
Routine laboratory blood tests predict SARS-CoV-2 infection using machine learning
Yang, H. S., Vasovic, L. V., Steel, P., Chadburn, A., Hou, Y., Racine-Brzostek, S. E., Cushing, M., Loda, M., Kaushal, R., Zhao, Z., Wang, F.
10.1101/2020.06.17.20133892 — Posted: 2020-06-19
Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France
Sbidian, E., Josse, J., Lemaitre, G., Mayer, I., Bernaux, M., Gramfort, A., Lapidus, N., Paris, N., Neuraz, A., Lerner, I., Garcelon, N., Rance, B., Grisel, O., Moreau, T., Bellamine, A., Wolkenstein, P., Varoquaux, G., Caumes, E., Lavielle, M., Mekontso Dessap, A., Audureau, E.
10.1101/2020.06.16.20132597 — Posted: 2020-06-19 Discussion: Onsite
Leveraging wearable technology to predict the risk of COVID-19 infection.
Miller, D. J., Capodilupo, J. V., Lastella, M., Sargent, C., Roach, G. D., Lee, V. H., Capodilupo, E. R.
10.1101/2020.06.18.20131417 — Posted: 2020-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).